Paid Research Study
Explore a New Care Option for Depression or Anxiety.
A Psychedelic Clinical Study may help you! Apply today!
Now enrolling new participants
Limited Spots - Earn up to $2275 if qualified
Study Only Available in English
Study Details
This study is evaluating the effectiveness of a one time investigational treatment for people with depression or anxiety
Get Started
Enter your information below to let our team know you're interested in participating in this Psychedelic Depression or Anxiety study
The Purpose Behind This Clinical Trial
Exploring Psychedelic Research: A New Frontier in Mental Health
Be Part of the Breakthrough: The Power of Participants
Exploring Psychedelic Research: A New Frontier in Mental Health
(FAQ) Frequently Asked Questions
You may qualify if you:
-
Are between 18 and 65 years old
-
Have been diagnosed with Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD)
-
Are currently experiencing moderate to severe symptoms
Final eligibility will be determined by the clinical team through a detailed screening process.
This study is designed to explore whether psychedelic-assisted therapy can support emotional well-being in individuals with depression or anxiety. Participants receive either the investigational compound or a placebo, under supervised clinical care, with support before and after dosing to process their experiences.
If you qualify:
-
You’ll begin with preparation sessions with trained facilitators
-
You will have 1 or 2 supervised dosing sessions at our clinic
-
After dosing, you’ll participate in integration therapy sessions to discuss your experience
Participation in this study is completely voluntary. You can withdraw at any time, for any reason, without any penalty or loss of benefits. Just let the study team know, and they will guide you through the process to ensure a safe and respectful exit from the study.
Paid Depression or Anxiety Research Study
What's Involved?
Get Signed Up
Enter your information and answer a few questions about yourself.
Participating
If you qualify, a research doctor will review the study with you and answer any questions prior to joining!
Discussion
Research staff will reach out to ask a few questions about your medical history.
Special Access
Log in any time to access new studies, see what you've signed up for, and update your information.
Get Signed Up
Enter your information and answer a few questions about yourself.
Participating
If you qualify, a research doctor will review the study with you and answer any questions prior to joining!
Discussion
Research staff will reach out to ask a few questions about your medical history.
Special Access
Log in any time to access new studies, see what you've signed up for, and update your information.
What's the Importance of this Trial?
Who Can Participate in a Clinical Trial?
Why are Psychedelic been Studied?
Psychedelics for MDD & GAD: Exploring New Frontiers
Living with Major Depressive Disorder (MDD) or Generalized Anxiety Disorder (GAD) often means dealing with persistent emotional pain, fatigue, and worry — even when on standard treatments.
Despite available medications, many individuals still experience breakthrough symptoms or inadequate relief. That’s why researchers are exploring psychedelic-assisted care as a potential new approach.
These clinical trials are designed to evaluate how psychedelic compounds — administered with professional psychological support — could reshape the future of care for those who need more options